Preliminary verification of the regulatory role of the novel_circ_0003012/mmu-miR-298-3p/Smoc2 signaling axis in the pathology of AD showed that it involved the downregulation of PKG. This evidence concerns the gene SMOC2 and Alzheimer disease.